Unknown

Dataset Information

0

Hydroxychloroquine in COVID-19: Potential Mechanism of Action Against SARS-CoV-2.


ABSTRACT: Purpose of Review:The rapid spread of virus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has turned out to be a global emergency. Symptoms of this viral infection, coronavirus disease 2019 (COVID-19), include mild infections of the upper respiratory tract, viral pneumonia, respiratory failure, multiple organ failure and death. Till date, no drugs have been discovered to treat COVID-19 patients, and therefore, a considerable amount of interest has been shown in repurposing the existing drugs. Recent Findings:Out of these drugs, chloroquine (CQ) and hydroxychloroquine (HCQ) have demonstrated positive results indicating a potential antiviral role against SARS-CoV-2. Its mechanism of action (MOA) includes the interference in the endocytic pathway, blockade of sialic acid receptors, restriction of pH mediated spike (S) protein cleavage at the angiotensin-converting enzyme 2 (ACE2) binding site and prevention of cytokine storm. Unfortunately, its adverse effects like gastrointestinal complications, retinopathy and QT interval prolongation are evident in treated COVID-19 patients. Yet, multiple clinical trials have been employed in several countries to evaluate its ability in turning into a needed drug in this pandemic. Summary:This review attempts to summarize the MOA of CQ/HCQ and its side effects. The existing literature hints that till date, the role of CQ/HCQ in COVID-19 may be sceptical, and further studies are warranted for obtaining a therapeutic option that could be effectively used across the world to rise out from this pandemic.

SUBMITTER: Satarker S 

PROVIDER: S-EPMC7443392 | biostudies-literature | 2020 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications

Hydroxychloroquine in COVID-19: Potential Mechanism of Action Against SARS-CoV-2.

Satarker Sairaj S   Ahuja Tejas T   Banerjee Madhuparna M   E Vignesh Balaji VB   Dogra Shagun S   Agarwal Tushar T   Nampoothiri Madhavan M  

Current pharmacology reports 20200824 5


<h4>Purpose of review</h4>The rapid spread of virus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has turned out to be a global emergency. Symptoms of this viral infection, coronavirus disease 2019 (COVID-19), include mild infections of the upper respiratory tract, viral pneumonia, respiratory failure, multiple organ failure and death. Till date, no drugs have been discovered to treat COVID-19 patients, and therefore, a considerable amount of interest has been shown in repurposi  ...[more]

Similar Datasets

| S-SCDT-EMM-2022-15904 | biostudies-other
| S-EPMC7430563 | biostudies-literature
| S-EPMC7390782 | biostudies-literature
| S-EPMC7128678 | biostudies-literature
| S-EPMC7243790 | biostudies-literature
| S-EPMC7430291 | biostudies-literature
2021-04-24 | GSE166424 | GEO
| S-EPMC7441757 | biostudies-literature
| S-EPMC7184359 | biostudies-literature
| S-EPMC8836247 | biostudies-literature